Latest Novo Nordisk Stories

2013-10-02 23:00:17

In-demand research study “Diabetes: Battle for ascendancy escalates in expanding market – KOL Insight” worked out by FirstWord has been recently published by Market Publishers Ltd. According to the report, the diabetes market was valued at more than USD 34 billion as of 2012. London, UK (PRWEB) October 03, 2013 During 2007-2012, the diabetes market experienced robust growth, recording a 10% CAGR. The rise in obesity, drug prices and disease prevalence has allowed diabetes drug sales...

2013-09-30 23:26:54

Reportbuyer.com just published a new market research report: Diabetes Treatments: World Drug Market 2013-2023. London (PRWEB) September 30, 2013 Report Details How to find trends, opportunities and revenue prospects in treating diabetes Where's the diabetic treatments market heading? How are those products performing? Visiongain's updated report gives you forecasted revenues there to 2023 and also explains R&D trends, outlooks and commercial opportunities. Our study lets you...

2013-09-24 23:27:47

Global Hemophilia Market Report: 2013 Edition research studies the hemophilia market on a global scale and its various segments. Dallas, Texas (PRWEB) September 24, 2013 The key trends observed within the global hemophilia market include inclination towards prophylaxis, long-acting factor VIII and IX development and growing penetration of rFVIII products in emerging markets which is a opportunity for manufacturers. On the development front, there has been an increase in the launch of new...

2013-09-06 23:21:39

d’Oliveira & Associates has posted a new infographic about the type-2 diabetes drug Victoza. The law firm now works with experienced lawyers, who are filing cancer lawsuits. (PRWEB) September 06, 2013 Victoza (liraglutide) is a once-daily injection used to control blood sugar levels in type-2 diabetes patients. This medicine increases insulin while making the stomach feel full. The FDA approved this drug in January 2010 and it earned more than $2.3 billion in sales its first year...

2013-08-29 23:02:45

The firm is currently evaluating Byetta, Victoza and Januvia lawsuits for those who have suffered from the drugs’ alleged potentially serious side effects, such as pancreatic cancer and thyroid cancer. (PRWEB) August 29, 2013 Byetta, Januvia and Victoza lawsuits were consolidated on Aug. 28 in federal district court in California, according to court documents. The Rottenstein Law Group LLP, a diabetes drug law firm, explains what this means for those looking to file lawsuits over the...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'